ERYTECH provides financial update for Q2 2013 admERY July 18, 2013 Newsroom ERYTECH announced today its cash position and its revenues for the second quarter of 2013. You Might Also Like ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016 ERYTECH to Present at Jefferies Virtual Healthcare Conference November 12, 2020 ERYTECH announces two positive DSMB reviews June 22, 2015
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
